Verrica Pharmaceuticals Inc. financial data

Symbol
VRCA on Nasdaq
Location
10 North High Street, Suite 200, West Chester, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 140 % -49.2%
Quick Ratio 8.36 % -26.5%
Debt-to-equity -380 % +61.7%
Return On Equity 165 % -87.3%
Return On Assets -59 % +59.6%
Operating Margin -263 % +54.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.49M shares -79.2%
Common Stock, Shares, Outstanding 9.49M shares -79.2%
Entity Public Float 190M USD +24.7%
Common Stock, Value, Issued 1K USD -80%
Weighted Average Number of Shares Outstanding, Basic 9.49M shares +103%
Weighted Average Number of Shares Outstanding, Diluted 9.49M shares +103%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 14.3M USD
Revenue from Contract with Customer, Excluding Assessed Tax 14.7M USD +5.72%
Cost of Revenue 2.6M USD 0%
Research and Development Expense 7.5M USD -56.4%
General and Administrative Expense 17.4M USD -25.8%
Operating Income (Loss) -16.4M USD +78.9%
Nonoperating Income (Expense) -9.61M USD -30.9%
Net Income (Loss) Attributable to Parent -26M USD +69.4%
Earnings Per Share, Basic 7 USD/shares +99.4%
Earnings Per Share, Diluted 7 USD/shares +99.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 21.1M USD -8.11%
Cash, Cash Equivalents, and Short-term Investments 10M USD
Accounts Receivable, after Allowance for Credit Loss, Current 7.05M USD
Inventory, Net 2.3M USD -10.8%
Assets, Current 36.3M USD +28.7%
Property, Plant and Equipment, Net 225K USD -65.4%
Operating Lease, Right-of-Use Asset 616K USD -32.5%
Other Assets, Noncurrent 376K USD -30.1%
Assets 40.9M USD +24.2%
Accounts Payable, Current 1.59M USD +64.1%
Employee-related Liabilities, Current 1.79M USD -32.6%
Contract with Customer, Liability, Current 1.56M USD
Liabilities, Current 28.9M USD +37.5%
Operating Lease, Liability, Noncurrent 330K USD -50.4%
Liabilities 57.9M USD -13.5%
Retained Earnings (Accumulated Deficit) -317M USD -8.95%
Stockholders' Equity Attributable to Parent -17M USD +50%
Liabilities and Equity 40.9M USD +24.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.7M USD +36.4%
Net Cash Provided by (Used in) Financing Activities -4.06M USD -514%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 9.5M shares -79.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16.7M USD +18.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 21.1M USD -8.11%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.54M USD -16.4%
Deferred Tax Assets, Valuation Allowance 70.9M USD +32%
Deferred Tax Assets, Gross 71.4M USD +31.4%
Operating Lease, Liability 665K USD -32.1%
Depreciation 135K USD -74.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -67M USD -174%
Lessee, Operating Lease, Liability, to be Paid 703K USD -34.2%
Property, Plant and Equipment, Gross 1.26M USD -34.3%
Operating Lease, Liability, Current 335K USD +6.35%
Lessee, Operating Lease, Liability, to be Paid, Year Two 246K USD -32.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 366K USD +1.67%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 38K USD -57.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 54M USD +45.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 483K USD -22.2%
Share-based Payment Arrangement, Expense 3.39M USD -60.1%
Interest Expense 8.65M USD +35938%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%